These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 22561214)

  • 21. [The use of different doses of botulotoxin A in the treatment of early arm poststroke spasticity].
    Agafonova NV; Khasanova DR
    Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(10):68-71. PubMed ID: 25591520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of switching therapy from complexing protein-containing botulinum toxin type A to a formulation with low immunogenicity in spasticity after stroke: a case report.
    Santamato A; Ranieri M; Panza F; Frisardi V; Micello MF; Filoni S; Fiore P
    J Rehabil Med; 2012 Sep; 44(9):795-7. PubMed ID: 22915045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can botulinum toxin type A injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A randomized controlled trial comparing manual needle placement and ultrasound-guided injection techniques.
    Santamato A; Micello MF; Panza F; Fortunato F; Baricich A; Cisari C; Pilotto A; Logroscino G; Fiore P; Ranieri M
    J Neurol Sci; 2014 Dec; 347(1-2):39-43. PubMed ID: 25263601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benefits and Risks of Non-Approved Injection Regimens for Botulinum Toxins in Spasticity.
    Santamato A; Panza F
    Drugs; 2017 Sep; 77(13):1413-1422. PubMed ID: 28726023
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The setting of a botulinum toxin treatment service.
    Cavallini M
    Neurol Sci; 2014 May; 35 Suppl 1():49-50. PubMed ID: 24867836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-induced secondary treatment failure in a patient treated with botulinum toxin type A for glabellar frown lines.
    Stengel G; Bee EK
    Clin Interv Aging; 2011; 6():281-4. PubMed ID: 22162643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating muscle selection for botulinum toxin-A injections in adults with post-stroke upper limb spasticity.
    Baguley IJ; Nott MT; Turner-Stokes L; De Graaff S; Katrak P; McCrory P; de Abadal M; Hughes A
    J Rehabil Med; 2011 Nov; 43(11):1032-7. PubMed ID: 22031350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
    Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
    N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of motor end plate-targeted Botulinum toxin type A injections in children with cerebral palsyitle.
    Van Campenhout A; Bar-On L; Desloovere K; Molenaers G
    Acta Orthop Belg; 2015 Jun; 81(2):167-71. PubMed ID: 26280952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antibody-induced failure of botulinum toxin type A therapy in a patient with masseteric hypertrophy.
    Lee SK
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S105-10. PubMed ID: 17278332
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of specific immune responses to BoNT/A and tetanus toxoid in patients undergoing treatment for neurologic disorders.
    Vlata Z; Tsatsakis A; Tzagournissakis M; Krambovitis E
    Endocr Metab Immune Disord Drug Targets; 2012 Sep; 12(3):268-73. PubMed ID: 22385115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
    El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
    J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of treatment with incobotulinum toxin A (botulinum neurotoxin type A free from complexing proteins; NT 201) in post-stroke upper limb spasticity.
    Kaňovský P; Slawek J; Denes Z; Platz T; Comes G; Grafe S; Pulte I
    J Rehabil Med; 2011 May; 43(6):486-92. PubMed ID: 21533328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S; Raimondi G; Guépratte N; Damiani S; Cillino M; Di Pace F; Casuccio A
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of botulinum A toxin in irreducible shoulder dislocation caused by spasm of pectoralis major.
    Sinha A; Higginson DW; Vickers A
    J Shoulder Elbow Surg; 1999; 8(1):75-6. PubMed ID: 10077801
    [No Abstract]   [Full Text] [Related]  

  • 36. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA; Brashear A; Gordon MF; Elovic EP; Turkel CC; Daggett S; Liu J; Brin MF
    Clin Ther; 2007 Apr; 29(4):683-90. PubMed ID: 17617291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High doses of onabotulinumtoxinA in post-stroke spasticity: a retrospective analysis.
    Baricich A; Grana E; Carda S; Santamato A; Cisari C; Invernizzi M
    J Neural Transm (Vienna); 2015 Sep; 122(9):1283-7. PubMed ID: 25724294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Focal spasticity therapy with botulinum toxin: effects on function, activities of daily living and pain in 100 adult patients.
    Bergfeldt U; Borg K; Kullander K; Julin P
    J Rehabil Med; 2006 May; 38(3):166-71. PubMed ID: 16702083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.